Chunxiao Yu Selected Research

MicroRNAs (MicroRNA)

1/2020	A nanobody targeting the LIN28:let-7 interaction fragment of TUT4 blocks uridylation of let-7.
12/2018	MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting NF2 in Human Papillary Thyroid Cancer.
5/2014	Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunxiao Yu Research Topics

Disease

8	Hypothyroidism 12/2020 - 10/2010
7	Obesity 01/2023 - 01/2015
6	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2014
5	Inflammation (Inflammations) 12/2023 - 10/2014
5	Hypercholesterolemia 12/2023 - 10/2010
5	Insulin Resistance 10/2023 - 04/2014
5	Fatty Liver 01/2023 - 01/2014
4	Male Infertility (Male Sterility) 12/2023 - 08/2017
4	Body Weight (Weight, Body) 08/2023 - 01/2018
4	Atherosclerosis 02/2022 - 05/2014
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2014
3	Carcinogenesis 01/2020 - 01/2016
3	Dyslipidemias (Dyslipidemia) 01/2019 - 08/2012
3	Prostatic Neoplasms (Prostate Cancer) 05/2008 - 12/2006
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 01/2021
2	Abdominal Obesity 09/2018 - 01/2016
2	Hypertriglyceridemia 06/2016 - 04/2014
1	Azoospermia 12/2023
1	Wilms Tumor (Wilm's Tumor) 12/2023
1	Neoplasms (Cancer) 12/2023
1	Bites and Stings (Sting) 10/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2022
1	Bronchiectasis 03/2022
1	Peripheral Arterial Disease 01/2022
1	COVID-19 01/2022
1	Osteoporosis 03/2021
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 09/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Hypertension (High Blood Pressure) 07/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Lymphatic Metastasis 12/2018
1	Neoplasm Metastasis (Metastasis) 12/2018
1	Leukemia 01/2018
1	Erectile Dysfunction 08/2017
1	Infertility (Sterility) 08/2017
1	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2017
1	Hemangioma (Angioma) 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 11/2016

Drug/Important Bio-Agent (IBA)

9	LipidsIBA 10/2023 - 08/2012
9	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2022 - 10/2010
7	Testosterone (Sustanon)FDA Link 01/2023 - 08/2017
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 04/2014
5	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2014
4	CholesterolIBA 12/2023 - 05/2012
4	Blood Glucose (Blood Sugar)IBA 10/2023 - 04/2014
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
4	Thyroid HormonesIBA 01/2015 - 05/2012
3	oxidized low density lipoproteinIBA 01/2023 - 04/2014
3	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2014
3	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2019 - 12/2013
2	Indicators and Reagents (Reagents)IBA 12/2023 - 03/2022
2	Metformin (Glucophage)FDA LinkGeneric 10/2023 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2023 - 05/2008
2	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2022
2	Insulin (Novolin)FDA Link 01/2022 - 04/2014
2	Estrogens (Estrogen)FDA Link 01/2019 - 08/2017
2	Aromatase (CYP19)IBA 09/2018 - 08/2017
2	AndrogensIBA 08/2017 - 12/2006
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017 - 01/2016
2	Follicle Stimulating Hormone (Follitropin)FDA Link 06/2016 - 01/2015
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014 - 12/2013
1	Oxidoreductases (Dehydrogenase)IBA 12/2023
1	EnzymesIBA 01/2023
1	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 01/2023
1	GalactosidasesIBA 01/2023
1	RNA Polymerase I (Polymerase I, RNA)IBA 09/2022
1	C-PeptideIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2022
1	Cystatin CIBA 01/2022
1	oligomycin sensitivity-conferring protein (complex V)IBA 01/2021
1	MucinsIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	LDL CholesterolIBA 01/2020
1	Uric Acid (Urate)IBA 07/2019
1	GoldIBA 01/2019
1	AntioxidantsIBA 01/2019
1	FSH Receptors (FSH Receptor)IBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 12/2018
1	Neurofibromin 2 (Merlin)IBA 12/2018
1	ParaffinIBA 12/2018
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2018
1	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 01/2018
1	VildagliptinIBA 01/2018
1	ElementsIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	SterolsIBA 01/2018
1	ZincIBA 01/2018
1	Aromatase InhibitorsIBA 08/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2017

Therapy/Procedure

1	Oral Administration 01/2022
1	Nephrectomy 09/2021
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018
1	Therapeutics 08/2017
1	Noninvasive Ventilation 11/2016